Key result
Oral ivabradine successfully controlled malignant junctional ectopic tachycardia and restored sinus rhythm in an infant following congenital heart surgery after conventional therapies failed.
Why the study?
Junctional ectopic tachycardia is the most common tachyarrhythmia after congenital heart surgery and increases morbidity and mortality, yet its management remains challenging despite available antiarrhythmic treatments.
Does oral ivabradine reverse malignant junctional ectopic tachycardia in infants following congenital heart surgery?
Case Report (n=1)
No
Does oral ivabradine reverse malignant junctional ectopic tachycardia in infants following congenital heart surgery?
Oral ivabradine may serve as a novel therapeutic option for refractory junctional ectopic tachycardia in infants following congenital heart surgery.
No takes yet. Share an insight, caveat, or question.
May offer rescue option in refractory postoperative JET; leaves open need for controlled trials.
Boulos et al. (2019) conducted a case report in Junctional ectopic tachycardia (JET) following congenital heart surgery (n=1). Ivabradine was evaluated on Conversion to sinus rhythm. Oral ivabradine successfully controlled malignant junctional ectopic tachycardia and restored sinus rhythm in an infant following congenital heart surgery after conventional therapies failed.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: